En Bloc transduction of imipenem resistance with other resistance determinants from a clinical strain of Pseudomonas aeruginosa

被引:6
|
作者
Babalova, M
Blahova, J
HupkovaLesicka, M
Krcmery, V
Schafer, V
机构
[1] Institute of Preventive and Clinical Medicine, 833 01 Bratislava
[2] Hygiene Institute University Clinics, Frankfurt/Main
关键词
transduction; antibiotic resistance; imipenem; cefotaxime; Pseudomonas aeruginosa; beta-lactamases;
D O I
10.1179/joc.1996.8.1.43
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this report we describe a lysogenic strain of Pseudomonas aeruginosa No. 229, from Frankfurt University Clinics, resistant to imipenem (IMI), cefotaxime (CTX), kanamycin (KAN), carbenicillin (CAR) as well as to other non-beta-lactam drugs, from which a wildtype phage could be isolated and used for transduction of an imipenem resistance determinant. All IMI-selected transductants were found to be co-resistant also to CTX, KAN and CAR. Conversely, transductants selected with CTX, KAN or CAR were also all resistant to IMI. It seems probable that IMI is hydrolyzed by the original donor strain as well as by transductant colonies by means of a clavulanate-inhibited beta-lactamase and not by a metallo-beta-lactamase.
引用
收藏
页码:43 / 46
页数:4
相关论文
共 50 条
  • [31] TRANSFERABLE RESISTANCE TO IMIPENEM IN HOSPITAL ISOLATES OF PSEUDOMONAS-AERUGINOSA
    HUPKOVA, M
    BLAHOVA, J
    BABALOVA, M
    KRCMERY, V
    SCHAFER, V
    [J]. JOURNAL OF CHEMOTHERAPY, 1993, 5 (01) : 14 - 16
  • [32] Imipenem resistance among Pseudomonas aeruginosa isolates:: Risk factors for infection and impact of resistance on clinical and economic outcomes
    Lautenbach, Ebbing
    Weiner, Mark G.
    Nachamkin, Irving
    Bilker, Warren B.
    Sheridan, Angela
    Fishman, Neil O.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (09): : 893 - 900
  • [33] DEVELOPMENT OF RESISTANCE TO PSEUDOMONAS-AERUGINOSA UNDER THERAPY WITH IMIPENEM
    KRECH, T
    NAUMANN, P
    [J]. IMMUNITAT UND INFEKTION, 1986, 14 (06): : 224 - 226
  • [34] PSEUDOMONAS-AERUGINOSA-ACQUIRED RESISTANCE TO IMIPENEM-CILASTATIN
    TIDWELL, BH
    CLEARY, JD
    [J]. PHARMACOTHERAPY, 1993, 13 (02): : 165 - 165
  • [35] Ciprofloxacin and imipenem resistance and cross-resistance in Pseudomonas aeruginosa: A single institution experience
    El Kary, Nadim
    El Rassy, Elie
    Azar, Nadim
    Choucair, Jacques
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (12) : 1736 - 1737
  • [36] Determinants of Intrinsic Aminoglycoside Resistance in Pseudomonas aeruginosa
    Krahn, Thomas
    Gilmour, Christie
    Tilak, Justin
    Fraud, Sebastien
    Kerr, Nicholas
    Lau, Calvin Ho-Fung
    Poole, Keith
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5591 - 5602
  • [37] TRANSDUCTION OF RESISTANCE TO IMIPENEM, AZTREONAM AND CEFTAZIDIME IN NOSOCOMIAL STRAINS OF PSEUDOMONAS-AERUGINOSA BY WILD-TYPE PHAGES
    BLAHOVA, J
    HUPKOVA, M
    BABALOVA, M
    KRCMERY, V
    SCHAFER, V
    [J]. ACTA VIROLOGICA, 1993, 37 (06) : 429 - 436
  • [38] CARBENICILLIN RESISTANCE IN PSEUDOMONAS AERUGINOSA FROM CLINICAL MATERIAL
    DARRELL, JH
    WATERWORTH, PM
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1969, 3 (5663): : 141 - +
  • [39] ANALYSIS OF ACQUIRED CIPROFLOXACIN RESISTANCE IN A CLINICAL STRAIN OF PSEUDOMONAS-AERUGINOSA
    MASECAR, BL
    CELESK, RA
    ROBILLARD, NJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) : 281 - 286
  • [40] Imipenem resistance associated with amino acid alterations of the OprD porin in Pseudomonas aeruginosa clinical isolates
    Nazari, Maryam
    Ahmadi, Hadi
    Hosseinzadeh, Shahnaz
    Sahebkar, Amirhossein
    Khademi, Farzad
    [J]. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2023, 70 (03) : 206 - 212